Page last updated: 2024-10-22

amiodarone and Amyloidosis

amiodarone has been researched along with Amyloidosis in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakazawa, T1
Murata, S1
Kondo, T1
Nakamura, N1
Yamane, T1
Iwasa, S1
Katoh, R1

Other Studies

1 other study available for amiodarone and Amyloidosis

ArticleYear
Histopathology of the thyroid in amiodarone-induced hypothyroidism.
    Pathology international, 2008, Volume: 58, Issue:1

    Topics: Aged; Amiodarone; Amyloidosis; Anti-Arrhythmia Agents; Female; Humans; Hypothyroidism; Multiple Myel

2008